Doxazosin
- Product NDC
- 71610-482
- 11-digit product format
- 716100482
- Labeler code
- 71610
- Product ID
- 71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA209013
- Marketing category
- ANDA
- Marketing start
- 2018-04-17
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-482-60 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-482 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20201212_6b74b18f-b89a-4109-a29e-c4fa65a3c5ee.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-482-60 | 71610048260 | 90 TABLET in 1 BOTTLE (71610-482-60) | 90 tablet | 2020-11-10 | 0000-00-00 | No | No | Current |